Overview

Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

Status:
Recruiting

Trial end date:
2021-06-15

Target enrollment:

Participant gender:

Summary

Helicobacter pylori infection causes active peptic ulcer disease and related complications like bleeding and pyloric obstruction. Usually, clinicians tended to treat Helicobacter pylori infection after active peptic ulcer disease and related complicaitons getting healed, which spent time and money. This study is designed to evaluate the efficacy and safety of intravenous administration of metronidazole, levofloxacin and esomeprazole triple therapy in the treatment of Helicobacter pylori infection combined with peptic ulcer disease related complications.

Phase:

Phase 4

Details

Lead Sponsor:

Shanghai Jiao Tong University School of Medicine

Treatments:

Esomeprazole
Levofloxacin
Metronidazole
Ofloxacin